Bubble Boy Disease Cured With Gene Therapy

The video discusses a promising new treatment for immune deficiency developed by Saint Jude Research Hospital. This treatment, which avoids the leukemia risk seen in past attempts, has shown success in trials with eight children. Mustang Bio, involved in the treatment, has seen a significant rise in its stock value. The company plans further research to seek FDA approval, which could have a positive impact on the industry.

What is the significance of the new treatment developed at Saint Jude Research Hospital?

How does the new treatment differ from the methods used 20 years ago?

What does the increase in Mustang Bio's shares indicate about investor confidence?

What are the implications of the treatment results for the company involved?

What challenges might the company face in obtaining FDA approval?